⚠ FOR RESEARCH USE ONLY • Not for human or animal consumption • Not intended to diagnose, treat, cure, or prevent any disease • Read full disclaimer
£0.00
This product is intended strictly for laboratory research and in-vitro studies.
NOT FOR HUMAN OR ANIMAL CONSUMPTIONS.
Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher or laboratory professional.
✓ CoA Verified
Original price was: £125.00.£90.00Current price is: £90.00.
Product Name: 2X Blend
Blend Components: CJC-1295 Without DAC / Ipamorelin
Research Category: GHRH Analog + Growth Hormone Secretagogue / Endocrine Research Peptide Blend
Peptide Type: Dual-Peptide Research Formulation
Primary Research Targets: Growth Hormone-Releasing Hormone Receptor (GHRHR) and Growth Hormone Secretagogue Receptor (GHSR)
Research Interest: Growth hormone signaling, pituitary physiology, GHRH and ghrelin receptor pathways, GH/IGF-1 axis, pulsatile endocrine signaling, and metabolic research.
CJC-1295 Without DAC: Commonly referred to as Modified GRF (1-29) or Mod GRF 1-29, this synthetic GHRH analog is investigated for its interaction with growth hormone-releasing hormone receptors and its effects on pituitary growth hormone signaling. The absence of a Drug Affinity Complex (DAC) distinguishes it from longer-acting DAC-modified CJC-1295.
Ipamorelin: A synthetic pentapeptide and growth hormone secretagogue that acts primarily through the growth hormone secretagogue receptor (GHSR), also known as the ghrelin receptor. It is investigated for its effects on growth hormone release and associated endocrine pathways.
The 2X Blend combines CJC-1295 Without DAC and Ipamorelin in a dual-peptide research formulation. The two components interact with distinct receptor systems involved in growth hormone regulation, making the combination of interest for experimental research into pituitary and endocrine signaling.
CJC-1295 Without DAC acts through GHRH receptors on pituitary somatotroph cells, while Ipamorelin activates the growth hormone secretagogue receptor. These separate receptor pathways are studied for their roles in regulating endogenous growth hormone signaling and downstream activity associated with the GH/IGF-1 axis.
Research involving this combination includes GHRH receptor biology, ghrelin receptor signaling, pituitary physiology, growth hormone secretion, GH/IGF-1 axis regulation, pulsatile endocrine signaling, and interactions between different growth hormone regulatory pathways.
Storage requirements depend on the final blend formulation and supplier. Research material should be stored according to the accompanying certificate of analysis (COA), product specification sheet, and manufacturer instructions.
CJC-1295 Without DAC and Ipamorelin are investigational research peptides. Information provided here is for scientific and research reference purposes only and should not be interpreted as medical, prescribing, or dosing advice.
Complete Your Stack
Researchers who bought this also added
Your Stack